Dr. Jart+

Dr. Jart+ is a South Korean skincare brand founded in 2004 by Lee Jin-Wook in collaboration with dermatologist Jung Sung-jae. The brand name was originally formed from Jung’s surname and the word “art,” reflecting an ambition to combine dermatological thinking with expressive visual design. The brand is commonly read as “Doctor Jart,” and its identity has developed around the meeting point of clinical skincare concepts, experimental formulation, and playful communication. The company’s early development began in 2003, when Lee Jin-Wook started researching BB cream. He approached Jung Sung-jae, who was working with patients experiencing severe skin problems and testing new treatment approaches. Jung became involved in developing and advising on the products, while Lee pursued the commercial expansion of the formulations. Dr. Jart+ spent approximately three years in development before entering dermatological clinics and was commercially launched in December 2004. Its initial distribution relied heavily on e-commerce, helping the brand reach consumers beyond the clinic setting. The brand reported revenue of 500 million won in 2005 and sales of seven billion won by 2008, according to the cited historical account. Lee emphasized exports from Asia in the company’s early years, reasoning that acceptance in Asian markets could support international growth. In June 2009, Dr. Jart+ entered a partnership with the Japanese department-store group Takashimaya at its former Fifth Avenue location in New York. This made it the second Korean cosmetics brand after Amorepacific to establish a presence there, according to the reference material. Dr. Jart+ entered the United States more broadly in early 2011 through Sephora, initially offering two BB creams at ten Sephora locations. It later expanded its Sephora presence internationally and became associated with the global Korean beauty wave. Rather than relying primarily on celebrity endorsements, the brand has used its own illustrations, animations, unconventional product names, and highly recognizable packaging to convey a witty and contemporary personality. This visual system helped distinguish it from more conventionally clinical or luxury skincare brands. The portfolio has included products organized around specific skin concerns and ingredient technologies. Its named lines have included Ceramidin for barrier care based on ceramides, Cicapair for calming and soothing skin with tiger grass or centella asiatica, Water Fuse and Water Drop for hydration, Dermaclear for cleansing and exfoliation, BB Cream for complexion correction, Peptide for peptide-based care, Focuspot for targeted patches, V7 for vitamin-focused products, and Cryo Rubber masks designed for intense moisturizing and soothing. Masks, serums, creams, cleansers, patches, BB creams, and sun-care products have all formed part of the broader assortment. In 2018, the brand refreshed its visual identity and packaging, beginning with the Ceramidin line. Although Dr. Jart+ is strongly associated with Korean beauty, brand consultant Ju Rhyu has described it as having a sufficiently clear identity that it has been able to avoid making the “K-beauty” label its sole positioning platform. The brand is therefore positioned between dermatologist-inspired skincare, premium beauty, and design-conscious consumer products. Its international expansion and distinctive product architecture have made it one of the better-known Korean skincare brands outside South Korea.

Dr. Jart+ developed from an early-2000s collaboration between entrepreneur Lee Jin-Wook and dermatologist Jung Sung-jae. Lee began researching BB cream in 2003 and sought Jung’s involvement because of the dermatologist’s work on treatments for patients with severe skin conditions. The brand’s name was initially created as a combination of “Jung” and “art,” expressing the intended relationship between dermatological expertise and creative presentation. The products were developed over roughly three years. Before their consumer launch, Dr. Jart+ products were introduced through dermatological clinics, providing an initial connection to professional skincare. Commercial sales began in December 2004, with e-commerce serving as an important early channel. The brand’s reported revenue reached 500 million won in 2005 and sales reached seven billion won by 2008, figures presented in the cited Wikipedia account. International expansion was a central part of the early strategy. Lee concentrated on exporting from Asia and treated regional popularity as a potential foundation for overseas growth. In June 2009, Dr. Jart+ partnered with Takashimaya at the department store’s former Fifth Avenue location. The New York presence gave the Korean brand visibility in a major international beauty market and followed Amorepacific as an early Korean cosmetics entrant there. The brand expanded into the United States in early 2011 through Sephora. Its initial American offer consisted of two BB creams available at ten Sephora locations. Over time, the Sephora relationship and other international distribution helped Dr. Jart+ build a broader global footprint, with the brand eventually offering approximately 50 products through Sephora outlets worldwide according to the reference account. Dr. Jart+ became associated with the Korean beauty wave but differentiated itself through more than country-of-origin marketing. Its communication has generally emphasized proprietary illustrations, animations, unusual naming, and packaging rather than depending on celebrity spokespeople. This approach gave the brand a recognizable personality that could sit alongside its dermatologist-inspired claims and ingredient-focused product lines. The portfolio expanded into several lines organized by skin concern or formulation concept. Cicapair centered on tiger grass, Ceramidin on ceramides and barrier support, Water Fuse and Water Drop on hydration, Dermaclear on cleansing, Peptide on peptide complexes, Focuspot on targeted patches, V7 on a multivitamin complex, and Cryo Rubber on mask-based moisturization and soothing. BB Cream remained an important category because the brand’s early development was closely connected to BB cream research. In 2018, Dr. Jart+ began refreshing its packaging and visual identity, with the Ceramidin range among the first lines to receive the new treatment. The brand has continued to balance clinical references with premium beauty design. Its international positioning is not limited to being a Korean brand: commentary cited in the source material suggests that Dr. Jart+ has sought to rely on a clear independent identity rather than making the K-beauty label its only point of distinction.

1. 2018Visual identity refresh begins

   Dr. Jart+ refreshed its branding and packaging, beginning with the Ceramidin line.

   Source
2. 2011United States launch through Sephora

   The brand entered the United States with two BB creams at ten Sephora stores.

   Source
3. 2009New York department-store entry

   Dr. Jart+ partnered with Takashimaya to sell products at its former Fifth Avenue location.

   Source
4. 2008Sales reach seven billion won

   The cited account states that Dr. Jart+ sales had reached seven billion won by this year.

   Source
5. 2005Early revenue milestone

   The cited historical account reports revenue of 500 million won for the year.

   Source
6. 2004Dr. Jart+ is commercially launched

   After approximately three years of development and an initial connection with dermatological clinics, the brand launched commercially in December.

   Source
7. 2003BB cream research begins

   Lee Jin-Wook began researching BB cream and subsequently approached dermatologist Jung Sung-jae to help develop the concept.

   Source

Premium dermatologist-inspired skincare combining Korean formulation expertise, treatment-oriented ingredients, and distinctive art-led branding.

• CicapairSoothing skincare

  A line centered on tiger grass, commonly identified with centella asiatica, and positioned around calming visible redness and soothing irritated-feeling skin. It represents one of Dr. Jart+’s best-known ingredient- and concern-led ranges.

• CeramidinBarrier-care skincare

  A ceramide-focused range built around the brand’s 5-Cera Complex concept. Products in the line are designed to support the skin barrier and address dryness through creams and related moisturizing formats.

• Water FuseHydration skincare

  A hydration-oriented line associated with an Aqua Mineral Complex. Its positioning emphasizes replenishing moisture and improving the feel of dehydrated skin.

• BB CreamComplexion skincare

  Dr. Jart+’s BB cream products connect directly to the company’s original research focus. They combine skincare-oriented positioning with complexion correction and helped establish the brand in international markets, including through its initial Sephora launch in the United States.

• DermaclearCleansing and exfoliation

  A cleansing-focused range associated with Hydrogen Bio Water. The line has included products intended to remove impurities and support cleansing or exfoliating routines.

• Water DropMoisturizers

  A hydration line using hyaluronic acid and a distinctive emulsion concept that releases small water droplets when applied. Its sensory application experience is part of the product’s differentiation.

• PeptideAnti-aging skincare

  A peptide-based range built around an eight-peptide complex. It extends Dr. Jart+’s ingredient-specific approach into products positioned for firming, smoothing, or general skin-conditioning benefits.

• FocuspotTargeted treatments

  A collection of targeted patches using micro-tip technology. The products are designed to deliver a concentrated treatment to specific areas or skin concerns rather than functioning as general facial care.

• V7Vitamin skincare

  A vitamin-focused line based on the V7 Multi-Vitamin Complex. The cited formulation description identifies vitamins including B3, C, F, K3, B5, E, and H.

• Cryo RubberFacial masks

  A mask range using a rubber-like format and proprietary technology to deliver intensive moisturizing and soothing. The distinctive application format reinforces Dr. Jart+’s experimental and design-oriented product identity.

• 2018Ceramidin packaging and identity refresh

  Global

  Dr. Jart+ began a broader branding and packaging refresh with Ceramidin as an initial focus, reinforcing the line’s barrier-care identity and the brand’s distinctive visual language.

  Outcome. The refresh updated the presentation of a major product family while retaining the brand’s science-meets-art positioning.

  Source
• 2011Sephora United States launch

  United States

  Dr. Jart+ entered the United States through Sephora with two BB creams initially placed in ten stores, using a retail partnership to introduce its Korean skincare proposition to American consumers.

  Outcome. The brand expanded its Sephora presence internationally and later offered approximately 50 products through Sephora outlets globally, according to the cited account.

  Source

• 2018Refresh the brand identity and packagingStrategy

  Dr. Jart+ sought to update its visual presentation while maintaining a recognizable identity centered on science, art, and product experimentation.

  What changed. The company began refreshing branding and packaging, starting with the Ceramidin line.

  Aftermath. The update preserved the brand’s distinctive design-led positioning and gave a major product family a more contemporary presentation.

  Source
• 2011Launch two BB creams through SephoraProduct launch

  The brand selected BB creams for its initial United States retail launch, consistent with its early product-development history.

  What changed. Two BB creams were introduced at ten Sephora locations.

  Aftermath. The Sephora relationship became an important international distribution channel for the expanding product range.

  Source
• 2009Use Asian popularity as a platform for overseas expansionStrategy

  In its early years, the brand focused strongly on exporting from Asia and treated regional acceptance as a basis for entering Western markets.

  What changed. Dr. Jart+ pursued international retail partnerships, including its Takashimaya placement in New York.

  Aftermath. The strategy preceded the brand’s United States entry through Sephora in 2011 and its subsequent international distribution growth.

  Source

• 2018Dr. Jart+ refreshes its branding and packaging

  The brand began a visual and packaging refresh with the Ceramidin line as an initial focus.

  Other
  Source
• 2011Dr. Jart+ launches in the United States through Sephora

  Dr. Jart+ entered the American market through Sephora, initially placing two BB creams in ten stores.

  M&AProduct launch
  Source
• 2009Dr. Jart+ enters the Takashimaya Fifth Avenue store

  The brand partnered with Takashimaya to sell its products at the department store’s former Fifth Avenue location in New York.

  Other
  Source

1. Dr. Jart+